Back

Atrial fibrillation screening on holter monitoring after percutaneous patent foramen ovale closure: a prospective study

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Interventional Cardiology ePosters Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Florence Leclercq

University Hospital Arnaud de Villeneuve, Montpellier (France)

133 More presentations in this session

Presentation thumbnail
Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.
Doctor M. Verdoia (Biella, IT)
Abstract Slides
Presentation thumbnail
Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Late outcomes of percutaneous coronary interventions (PCI) and subsequent life-quality in patients younger 40 years of age
Professor F. Abdullayev (Baku, AZ)
Abstract Slides
Presentation thumbnail
Rapid pacing is an independent predictor for high implantation depth using self-expandable devices in TAVR
Assistant Professor V. Veulemans (Duesseldorf, DE)
Abstract Slides
Presentation thumbnail
Influence of the speed of deflation of the stent delivery system in the myocardial blush and st-segment resolution in primary angioplasty: a randomized study
Doctor I. Lozano Martinez-Luengas (Gijon, ES)
Abstract Slides

Access the full session

Session thumbnail
Interventional Cardiology ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
A reversible cause of heart failure?
thumbnail
Congress Presentation
Navigating anatomical barriers: successful amplatzer closure of a high-risk patent foramen ovale after failed noblestitch
thumbnail
Congress Presentation
Anatomical classification of patent foramen ovale before percutaneous closure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources